CAM
MOR

Cresset Asset Management’s MorphoSys AG American Depositary Shares MOR Stock Holding History

Cresset Asset Management’s Portfolio MOR Stock Details MOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-35,506
Closed -$334K – 1173
2021
Q4 		$334K Buy
35,506
+14,129
+66% +$150K ﹤0.01% 842
2021
Q3 		$252K Buy
21,377
+9,421
+79% +$136K ﹤0.01% 924
2021
Q2 		$230K Buy
+11,956
New +$256K ﹤0.01% 894

Other funds holding MOR

Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
HJIM
Henry James International Management New York $334M AUM 49.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cresset Asset Management's MOR Position: Q1 2022 in Review

Cresset Asset Management sold out of MorphoSys AG American Depositary Shares (MOR) in Q1 2022, closing a stake of 35,506 shares — an estimated $334K sold.

Cresset Asset Management first reported a position in MOR in Q2 2021 and held it in 3 quarters. The position peaked at $334K in Q4 2021. 23 funds tracked by Wall St. Rank hold MOR as of Q1 2022.

  • Cresset Asset Management reported no remaining MorphoSys AG American Depositary Shares position as of Q1 2022 after selling out during the quarter.
  • Cresset Asset Management sold 35,506 MorphoSys AG American Depositary Shares shares in Q1 2022, an estimated $334K.
  • Cresset Asset Management first reported a position in MorphoSys AG American Depositary Shares in Q2 2021 and held it in 3 quarters.
  • Cresset Asset Management's MorphoSys AG American Depositary Shares position peaked at $334K in Q4 2021.
  • 23 funds tracked by Wall St. Rank held MorphoSys AG American Depositary Shares as of Q1 2022.

Based on Cresset Asset Management's 13F filing for Q1 2022, filed 16 May 2022.